Objectives: MicroRNAs (miRNAs) are short, endogenous noncoding RNA molecules that can bind to parts of target mRNAs, thereby regulating gene expression. Few studies have shown that microRNAs can be up or down-regulated in allergic skin conditions but still, there is a need for further studies. The aim of this study was to investigate the expression of miRNAs in response to the common contact allergen Bandrowski's base (BB), the principal allergen in patients reacting to pphenylenediamine (PPD).
INTRODUCTION
Immunotoxic agents are xenobiotics which can initiate or exacerbate the adverse immune responses in genetically-susceptible persons. Drugs and various chemicals can be classified as immunotoxic compounds. 1 When low molecular weight chemicals contact with skin that can lead to contact allergy and can cause allergic contact dermatitis (ACD) if exposure exceeds the personal threshold. ACD is a more common form of immunotoxic reactions in industrialized countries. 2 There are more than 4000 chemicals are linked to contact allergy and ACD in humans. ACD can be prevented by proper hazard identification and labeling; by characterization of potency; by an investigating of human skin exposure; and by the implementation of proper risk assessment and management strategies. THP-1 is a human leukemia promyelocytic cell line and it has been widely used in the immunotoxicology studies which investigate the monocyte/macrophage functions, its mechanisms, and signaling pathways. This cell line has become a proper model to estimate the modulation of monocyte and macrophage activities and very well suited to the in vitro studies of chemical allergens. [5] [6] [7] miRNAs are a class of evolutionarily conserved, single-stranded, noncoding RNA molecules including 19-24 nucleotides, that play an important role in various of biological processes via regulating the gene expression through affecting the transcriptional and translation processes. 8 miRNAs have also been implicated in several inflammatory and immunological disorders as well as cancer. 9 It was demonstrated that miR-21 and miR-155 have a significant role in the development of u n c o r r e c t e d p r o o f the immune system. miR-21 controls the apoptosis of immune cells and miR-155 is an important factor controlling lymphocyte differentiation and functions. 10, 11 Analysis of microRNAs (miRNAs) has powerful potential for the identification of novel prognostic or predictive biomarkers. However several studies have evaluated the impact of miRNAs on the immunotoxic processes and allergic skin conditions, these studies are not enough to draw a conclusion. 12 Therefore the aim of the study was to evaluation of miRNA profiles that might have a role in the chemical allergen potency. 
MATERIALS AND METHODS

Cell
Statistical analysis
Data were analyzed by SPSS software, version 23.0 (SPSS, Chicago, IL, USA).
Normal distribution and homogeneity of the variances were evaluated by ShapiroWilk and Levene's tests, respectively. Student's t-test was used for the comparisons.
p values less than 0.05 were considered statistically significant. 
Real-time PCR for the detection of miRNAs
Following bibliographic research, we focused on miR-21 and miR-155 because these are believed to be involved in immune responses. THP-1 cells were exposed to BB (1 µg/ml) or DMSO as a control for 24, 48 and 72 h. After the miRNA extraction, miR-21
and miR-155 levels were evaluated by Real Time-PCR. As shown in Figure 4 and 5, the expression of miR-21 was down-regulated and the expression of miR-155 was up-regulated, confirming the miRNA expression profile data.
*insert Figure 4 and 5
DISCUSSION
ACD is one of the significant diseases which occurred after the topical exposure to low molecular weight chemicals. 14, 15 It is one of the delayed-type hypersensitivity reaction which needs previous sensitization by the same chemical. 16 It is important and crucial to the identification of potential sensitizing agents because ACD is a common and serious health problem worldwide. Similarly, in a study by Sonkoly et al 23 , the expression of miR-155 was found to be highest in the skin samples from patients with atopic dermatitis compared to healthy controls. Also, it has been observed that after the topical exposure of relevant allergens to non-lesional skin of atopic dermatitis patients, miR-155 expression was induced. Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), a negative regulator of T-cell function has been repressed by miR-155 and in animal models blocking of CTLA-4 stimulated a much severe allergic reaction and inflammation by increasing the number of eosinophils and immunoglobulin-E, while increasing in the expression of CTLA-4 ameliorated the symptoms of allergic pulmonary inflammation in humans. 24, 25 Besides, in patients with atopic dermatitis miR-155 has significantly higher expression compared to healthy subjects and the levels of expression correlated with the severity of atopic dermatitis. 26 In contrast to these studies, miR-155 levels were lower in sputum from allergic asthmatics than in the healthy subjects. 27 miR-21 levels were evaluated in a few studies. In line with the results obtained from this study, it was shown that miR-21 was lower in monocytes from children with allergic rhinitis and in patients with metabolic syndrome 28, 29 . On the contrary, in an animal study, miR-21 levels were higher in mice skin with contact dermatitis and in esophageal tissue of Eosinophilic esophagitis of mice, which can be reflected interspecies differences between mice and humans in the miRNA expressions. 30, 31 In addition to involvement in various biological processes, miRNAs have potential in disease diagnostics and therapies. Due to their stability, miRNAs could be used as 
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